Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Pfizer Stock Slips After Report on Vaccine Timing Probe
In This Article:
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion that the pharmaceutical giant delayed announcing a successful Covid-19 vaccine until after the 2020 election.
Terms and Privacy Policy